Literature DB >> 1297005

Immune response to Echinococcus multilocularis infection in the mouse model: a review.

M C Playford1, M Kamiya.   

Abstract

Echinococcus multilocularis is a cestode helminth which, along with E. granulosus, E. oligarthus and E. vogeli is a causative agent of hydatid disease in man. In the intermediate host (including man), cysts formed by the metacestode (larval stage) develop in the internal organs, causing functional impairment which often leads to the death of the host. In this review larval E. multilocularis infection in mice, the most popular experimental intermediate host, is examined, and the immune response to the organism is described in detail. Evidence is presented which suggests that cell-mediated immunity (CMI) plays a large role in suppression of larval growth. Congenitally athymic nude mice, and mice treated to remove thymocytes had high susceptibility to infection, while mice strains assessed as having high helper T lymphocyte function showed resistance to infection. The degree of antibody response shown by the host does not correlate with the susceptibility to E. multilocularis. Infection with E. multilocularis is accompanied by immunosuppression, manifested by inhibition of effector cell chemotaxis and receptor expression, suppressor macrophage and lymphocyte activity, decline in helper T-lymphocyte activity and immune-complex deposition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1297005

Source DB:  PubMed          Journal:  Jpn J Vet Res        ISSN: 0047-1917            Impact factor:   0.649


  7 in total

1.  Echinococcus multilocularis infection in the field vole (Microtus agrestis): an ecological model for studies on transmission dynamics.

Authors:  Ian David Woolsey; Nethe Eva Touborg Bune; Per Moestrup Jensen; Peter Deplazes; Christian Moliin Outzen Kapel
Journal:  Parasitol Res       Date:  2015-02-08       Impact factor: 2.289

2.  Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs.

Authors:  Bruno Gottstein; Matthias Wittwer; Marc Schild; Michael Merli; Stephen L Leib; Norbert Müller; Joachim Müller; Rolf Jaggi
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

3.  Echinococcus multilocularis proliferation in mice and respective parasite 14-3-3 gene expression is mainly controlled by an alphabeta CD4 T-cell-mediated immune response.

Authors:  Wen Juan Dai; Andreas Waldvogel; Mar Siles-Lucas; Bruno Gottstein
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 4.  Concepts in immunology and diagnosis of hydatid disease.

Authors:  Wenbao Zhang; Jun Li; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

5.  Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.

Authors:  Junhua Wang; Dominique A Vuitton; Norbert Müller; Andrew Hemphill; Markus Spiliotis; Oleg Blagosklonov; Denis Grandgirard; Stephen L Leib; Itay Shalev; Gary Levy; Xiaomei Lu; Renyong Lin; Hao Wen; Bruno Gottstein
Journal:  PLoS Negl Trop Dis       Date:  2015-05-08

6.  Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model.

Authors:  Xinling Hou; Yang Shi; Xuejiao Kang; Zibigu Rousu; Dewei Li; Maolin Wang; Abidan Ainiwaer; Xuran Zheng; MingKun Wang; Bahejiang Jiensihan; Liang Li; Jing Li; Hui Wang; Chuanshan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

7.  T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model.

Authors:  Chuanshan Zhang; Yingmei Shao; Shuting Yang; Xiaojuan Bi; Liang Li; Hui Wang; Ning Yang; Zhide Li; Cheng Sun; Liang Li; Guodong Lü; Tuerganaili Aji; Dominique A Vuitton; Renyong Lin; Hao Wen
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.